BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16160628)

  • 1. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial.
    Soyka M; Hock B; Kagerer S; Lehnert R; Limmer C; Kuefner H
    J Clin Psychopharmacol; 2005 Oct; 25(5):490-3. PubMed ID: 16160628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function.
    Shmygalev S; Damm M; Weckbecker K; Berghaus G; Petzke F; Sabatowski R
    Drug Alcohol Depend; 2011 Sep; 117(2-3):190-7. PubMed ID: 21353749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial.
    Soyka M; Lieb M; Kagerer S; Zingg C; Koller G; Lehnert P; Limmer C; Kuefner H; Hennig-Fast K
    J Clin Psychopharmacol; 2008 Dec; 28(6):699-703. PubMed ID: 19011441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less driving impairment on buprenorphine than methadone in drug-dependent patients?
    Soyka M; Horak M; Dittert S; Kagerer S
    J Neuropsychiatry Clin Neurosci; 2001; 13(4):527-8. PubMed ID: 11748323
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude.
    Baewert A; Gombas W; Schindler SD; Peternell-Moelzer A; Eder H; Jagsch R; Fischer G
    Eur Addict Res; 2007; 13(3):127-35. PubMed ID: 17570908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers.
    Strand MC; Vindenes V; Gjerde H; Mørland JG; Ramaekers JG
    Br J Clin Pharmacol; 2019 Feb; 85(2):442-453. PubMed ID: 30515857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration.
    Strand MC; Fjeld B; Arnestad M; Mørland J
    Traffic Inj Prev; 2013; 14(1):26-38. PubMed ID: 23259516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates.
    Rapeli P; Fabritius C; Kalska H; Alho H
    BMC Clin Pharmacol; 2011 Aug; 11():13. PubMed ID: 21854644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot study.
    Soyka M; Limmer C; Lehnert R; Koller G; Martin G; Küfner H; Kagerer S; Haberthür A
    Am J Drug Alcohol Abuse; 2011 Nov; 37(6):497-508. PubMed ID: 21851203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
    Rapeli P; Fabritius C; Alho H; Salaspuro M; Wahlbeck K; Kalska H
    BMC Clin Pharmacol; 2007 Jun; 7():5. PubMed ID: 17565668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.
    Rapeli P; Fabritius C; Kalska H; Alho H
    Subst Abuse Treat Prev Policy; 2012 Nov; 7():45. PubMed ID: 23121989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive-motor performance of methadone-maintained patients.
    Specka M; Finkbeiner T; Lodemann E; Leifert K; Kluwig J; Gastpar M
    Eur Addict Res; 2000 Mar; 6(1):8-19. PubMed ID: 10729738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients.
    Dagtekin O; Gerbershagen HJ; Wagner W; Petzke F; Radbruch L; Sabatowski R
    Anesth Analg; 2007 Nov; 105(5):1442-8, table of contents. PubMed ID: 17959980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance therapy with synthetic opioids and driving aptitude.
    Schindler SD; Ortner R; Peternell A; Eder H; Opgenoorth E; Fischer G
    Eur Addict Res; 2004; 10(2):80-7. PubMed ID: 15004452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
    Ling W; Wesson DR; Charuvastra C; Klett CJ
    Arch Gen Psychiatry; 1996 May; 53(5):401-7. PubMed ID: 8624183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers.
    Mintzer MZ; Correia CJ; Strain EC
    Drug Alcohol Depend; 2004 May; 74(2):205-9. PubMed ID: 15099664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of Single Doses of Methadone and Buprenorphine in Blood and Oral Fluid in Healthy Volunteers and Correlation With Effects on Psychomotor and Cognitive Functions.
    Strand MC; Ramaekers JG; Gjerde H; Mørland J; Vindenes V
    J Clin Psychopharmacol; 2019; 39(5):489-493. PubMed ID: 31305338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent.
    Compton P; Charuvastra VC; Ling W
    Drug Alcohol Depend; 2001 Jul; 63(2):139-46. PubMed ID: 11376918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine.
    Konijnenberg C; Sarfi M; Melinder A
    Early Hum Dev; 2016 Oct; 101():91-7. PubMed ID: 27614330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.